Specify a stock or a cryptocurrency in the search bar to get a summary
Jenscare Scientific Co Ltd
9877Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of interventional products for the treatment of structural heart diseases in the People's Republic of China. It offers LuX-Valve and LuX-Valve Plus, a transcatheter tricuspid valve replacement (TTVR) product for the treatment of severe tricuspid regurgitation and high surgical risk; and Ken-Valve, a transcatheter aortic valve replacement product candidate for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops JensClip, a clip-based transcatheter mitral valve (TMVR) repair system, and JensRelive, a TMVR transfemoral system to treat patients with severe mitral regurgitation; MicroFlux, a transcatheter device to treat heart failure with pressured ejection fraction; and SimuLock, a bionics left atrial appendage occluder system for cardiogenic stroke prevention. In addition, it is involved in consulting and investment activities. The company was incorporated in 2011 and is headquartered in Ningbo, the People's Republic of China. Address: Block 5, B Area, Ningbo, China
Analytics
WallStreet Target Price
342.61 HKDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 9877
Dividend Analytics 9877
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 9877
Stock Valuation 9877
Financials 9877
Results | 2019 | Dynamics |